Health Canada establishment

Boehringer Ingelheim Pharma GmbH & Co. KG

Health Canada establishment 502156

Key facts

Reference number 502156
Establishment Boehringer Ingelheim Pharma GmbH & Co. KG

At a glance

  • 10–99 Health Canada inspections

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Health Canada inspected establishments

Health Canada inspects the establishments that fabricate, package, label, test, import, distribute or wholesale drugs for the Canadian market. Clinical trial sites, which can name individuals, are not published here.

Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada

Browse all Health Canada inspected establishments